News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

January 17, 2025
January 17, 2025
Categories

The Winter 2025 advocacy blog Considering Clinical Trials is now available

Do you like it?
Read more
January 16, 2025
January 16, 2025
Categories

Major breast cancer screening trial hits enrollment goal (features TMIST)

Do you like it?
Read more
January 16, 2025
January 16, 2025
Categories

TMIST breast cancer screening trial reaches enrollment milestone, advancing precision screening techniques

Do you like it?
Read more
January 15, 2025
January 15, 2025
Categories

Press Release: Large-scale TMIST breast cancer screening trial achieves enrollment goal, paving the way for data that provides a precision approach to screening

More than 108,000 women across the world joined the TMIST breast cancer screening trial of 2-D versus 3-D mammography
Do you like it?
Read more
January 14, 2025
January 14, 2025
Categories

Cellular therapies and novel targeted agents will shape the future of acute lymphoblastic leukemia management (mentions E1910)

Do you like it?
Read more
January 10, 2025
January 10, 2025
Categories

Adjuvant tamoxifen reduces 15-year risk of recurrence in ‘good risk’ DCIS without radiation therapy (mentions E5194)

Do you like it?
Read more
January 8, 2025
January 8, 2025
Categories

WATCH: A recent FDA approval of blinatumomab was supported by data from the E1910 trial

Do you like it?
Read more
January 8, 2025
January 8, 2025
Categories

Active monitoring is promising for women with low-risk ductal carcinoma in situ (features E5194)

Do you like it?
Read more
January 6, 2025
January 6, 2025
Categories

Can we omit stem cell transplants in patients with mantle cell lymphoma with undetectable residual disease? (features EA4151)

Do you like it?
Read more
January 5, 2025
January 5, 2025
Categories

NCI’s myeloMATCH precision medicine initiative pushes the envelop in myeloid leukemia care

Do you like it?
Read more
January 3, 2025
January 3, 2025
Categories

WATCH: Dr. Efrat Dotan on pancreatic cancer in older adults (features EA2186/GIANT)

Do you like it?
Read more
January 3, 2025
January 3, 2025
Categories

A delicate balance: Treating older patients with metastatic pancreas cancer (with EA2186/GIANT trial chair Efrat Dotan)

Do you like it?
Read more
December 18, 2024
December 18, 2024
Categories

How ECOG-ACRIN and Caris Life Sciences are teaming up to fight cancer

Do you like it?
Read more
December 13, 2024
December 13, 2024
Categories

Tamoxifen cuts 15-year recurrence in DCIS without radiation therapy

Do you like it?
Read more
December 12, 2024
December 12, 2024
Categories

Press Release: Adjuvant tamoxifen may reduce recurrence risk for patients with ‘good-risk’ DCIS who forgo radiation

Do you like it?
Read more
December 11, 2024
December 11, 2024
Categories

Does acalabrutinib fit into frontline therapy for patients with mantle cell lymphoma? (Study EA4181)

Do you like it?
Read more
December 10, 2024
December 10, 2024
Categories

Press Release: Autologous stem cell transplants do not improve survival for mantle cell lymphoma patients with undetectable MRD, clinical trial shows

Do you like it?
Read more
December 4, 2024
December 4, 2024
Categories

Upfront treatment and early intervention to get attention at ASH 2024, including mantle cell lymphoma with the striking results of study EA4151

Do you like it?
Read more
November 26, 2024
November 26, 2024
Categories

WATCH: David Schiff discusses the striking survival improvement for patients with low-grade brain tumors found in study E3F05

Do you like it?
Read more
November 26, 2024
November 26, 2024
Categories

The November 2024 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
Load more
News and Info

About Us Home Page

News and Info
Media Contact:
Diane Dragaud, MA
Director of Communications

Send an email

215-789-3631

Categories


Tags

Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Advocacy Bladder cancer Brain Cancer Breast cancer Cancer screening Cancer treatment Care delivery Chemotherapy Clinical trial ComboMATCH Disparities Diversity Gastric cancer Gene testing GI cancer Group meeting Head and neck cancer Health equity Hogkin lymphoma Immunotherapy In memory Leadership Leukemia Lung cancer Lymphoma Mammography Melanoma Mentorship NCI-MATCH Non-Hodgkin lymphoma Pancreatic cancer Personalized screening Personalized treatment Precision medicine Precision oncology Prostate cancer Radiology Research results Sarcoma Social determinants of health (SDoH) Survivorship TMIST Treatment trial

 
ECOG-ACRIN Cancer Research Group